190 related articles for article (PubMed ID: 1898893)
21. Follicle stimulating hormone (FSH) dynamics of low dose step-up ovulation induction with FSH in patients with polycystic ovary syndrome.
van der Meer M; Hompes PG; Scheele F; Schoute E; Veersema S; Schoemaker J
Hum Reprod; 1994 Sep; 9(9):1612-7. PubMed ID: 7836509
[TBL] [Abstract][Full Text] [Related]
22. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency.
Schoot DC; Coelingh Bennink HJ; Mannaerts BM; Lamberts SW; Bouchard P; Fauser BC
J Clin Endocrinol Metab; 1992 Jun; 74(6):1471-3. PubMed ID: 1592896
[TBL] [Abstract][Full Text] [Related]
23. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
van der Westhuizen S; van der Spuy ZM
Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
[TBL] [Abstract][Full Text] [Related]
24. Comparison of follicular vascularization in normal versus polycystic ovaries during in vitro fertilization as measured using 3-dimensional power Doppler ultrasonography.
Järvelä IY; Sladkevicius P; Kelly S; Ojha K; Campbell S; Nargund G
Fertil Steril; 2004 Nov; 82(5):1358-63. PubMed ID: 15533360
[TBL] [Abstract][Full Text] [Related]
25. Induction of ovulation with purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome.
Garcea N; Campo S; Panetta V; Venneri M; Siccardi P; Dargenio R; De Tomasi F
Am J Obstet Gynecol; 1985 Mar; 151(5):635-40. PubMed ID: 3919586
[TBL] [Abstract][Full Text] [Related]
26. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
[TBL] [Abstract][Full Text] [Related]
27. The value of laboratory tests and ultrasonography in evaluating ovarian response to ovulation induction treatment with low-dose recombinant follicle-stimulating hormone.
Ozkaya O; Kaya H; Sezik M; Akyürek C; Ozbaşar D
Int J Fertil Womens Med; 2004; 49(2):83-7. PubMed ID: 15188834
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group.
J Clin Endocrinol Metab; 1998 May; 83(5):1507-14. PubMed ID: 9589647
[TBL] [Abstract][Full Text] [Related]
29. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
[TBL] [Abstract][Full Text] [Related]
30. Gonadotropin-releasing hormone, estradiol, and inhibin regulation of follicle-stimulating hormone and luteinizing hormone surges: implications for follicle emergence and selection in heifers.
Haughian JM; Ginther OJ; Diaz FJ; Wiltbank MC
Biol Reprod; 2013 Jun; 88(6):165. PubMed ID: 23658431
[TBL] [Abstract][Full Text] [Related]
31. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
32. Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH.
Fleming R; Rehka P; Deshpande N; Jamieson ME; Yates RW; Lyall H
Hum Reprod; 2000 Jul; 15(7):1440-5. PubMed ID: 10875848
[TBL] [Abstract][Full Text] [Related]
33. Doppler, ultrasonographic and endocrinological environment with regard to the number of small subcapsular follicles in polycystic ovary syndrome.
Battaglia C; Genazzani AD; Salvatori M; Giulini S; Artini PG; Genazzani AR; Volpe A
Gynecol Endocrinol; 1999 Apr; 13(2):123-9. PubMed ID: 10399058
[TBL] [Abstract][Full Text] [Related]
34. Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH/LH ratios. I. Comparison of an FSH-dominant and a purified FSH preparation.
Duijkers IJ; Willemsen WN; Hollanders HM; Hamilton CJ; Thomas CM; Vemer HM
Int J Fertil Womens Med; 1997; 42(5):306-10. PubMed ID: 9406836
[TBL] [Abstract][Full Text] [Related]
35. The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries.
Barnes RB; Namnoum AB; Rosenfield RL; Layman LC
Hum Reprod; 2002 Jan; 17(1):88-91. PubMed ID: 11756367
[TBL] [Abstract][Full Text] [Related]
36. Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation.
Seibel MM; Kamrava MM; McArdle C; Taymor ML
Int J Fertil; 1984; 29(1):39-43. PubMed ID: 6146583
[TBL] [Abstract][Full Text] [Related]
37. [Follicular development in pregnancy and the polycystic ovarian syndrome].
Chikazawa K; Araki S; Tamada T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2195-200. PubMed ID: 3100704
[TBL] [Abstract][Full Text] [Related]
38. Induction of ovarian follicle luteinization by recombinant follicle-stimulating hormone.
Tapanainen JS; Lapolt PS; Perlas E; Hsueh AJ
Endocrinology; 1993 Dec; 133(6):2875-80. PubMed ID: 8243314
[TBL] [Abstract][Full Text] [Related]
39. Ovulatory follicle dysfunction in lactating dairy cows after treatment with Folltropin-V at the onset of luteolysis.
Giordano JO; Edwards JL; Di Croce FA; Roper D; Rohrbach NR; Saxton AM; Schuenemann GM; Prado TM; Schrick FN
Theriogenology; 2013 May; 79(8):1210-7. PubMed ID: 23534994
[TBL] [Abstract][Full Text] [Related]
40. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
Ashrafi M; Kiani K; Ghasemi A; Rastegar F; Nabavi M
Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
